Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 28 matching records.
28 results — page 1 of 2
- Level DAnimal StudyEurope PMC
Intravenous Human Umbilical Cord-Derived Mesenchymal Stromal Cells Promote Functional Recovery after Experimental Intracerebral Hemorrhage Via Local and Systemic Immunomodulation
Animal Study on Chronic Inflammation, Immune Modulation, published in Transl Stroke Res (2026) — summary generated from the PubMed abstract.
- 2026
Transl Stroke Res - Level DAnimal StudyPubMed
Immunomodulation effects of collagen hydrogel encapsulating extracellular vesicles derived from calcium silicate stimulated-adipose mesenchymal stem cells for diabetic healing.
Animal Study on Diabetic Foot, Chronic Wound, Chronic Inflammation, Immune Modulation, published in J Nanobiotechnology (2025) — summary generated from the PubMed abstract.
- 2025
J Nanobiotechnology15 citations - Level DAnimal StudyEurope PMC
Primed Mesenchymal Stem Cells by IFN-γ and IL-1β Ameliorate Acute Respiratory Distress Syndrome through Enhancing Homing Effect and Immunomodulation
Animal Study on Chronic Inflammation, Immune Modulation, published in Biomol Ther (Seoul) (2025) — summary generated from the PubMed abstract.
- 2025
Biomol Ther (Seoul)3 citations - Level DNarrative ReviewPubMed
A review of adipose-derived mesenchymal stem cells' impacts and challenges: metabolic regulation, tumor modulation, immunomodulation, regenerative medicine and genetic engineering therapies.
Narrative Review on Chronic Inflammation, Immune Modulation, published in Front Endocrinol (Lausanne) (2025) — summary generated from the PubMed abstract.
- 2025
Front Endocrinol (Lausanne)8 citations - Level BClinical TrialEurope PMC
The role and mechanism of mesenchymal stem cells in immunomodulation of type 1 diabetes mellitus and its complications: recent research progress and challenges: a review
Clinical Trial on Type 1 Diabetes, Immune Modulation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther2 citations - Level DAnimal StudyPubMed
Mesenchymal stromal cells conditioned by peripheral blood mononuclear cells exert enhanced immunomodulation capacities and alleviate a model of Myasthenia Gravis.
Animal Study on Immune Modulation, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther2 citations - Level DLaboratory StudyEurope PMC
PML-mediated nuclear loosening permits immunomodulation of mesenchymal stem/stromal cells under inflammatory conditions
Laboratory Study on Immune Modulation, published in Cell Prolif (2024) — summary generated from the PubMed abstract.
- 2024
Cell Prolif2 citations - Level CProspective StudyPubMed
Immunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19.
Prospective Study on Immune Modulation, published in World J Gastrointest Oncol (2024) — summary generated from the PubMed abstract.
- 2024
World J Gastrointest Oncol5 citations - Level DLaboratory StudyPubMed
Combination of Adult Mesenchymal Stem Cell Therapy and Immunomodulation with Dimethyl Fumarate Following Spinal Cord Ventral Root Repair.
Laboratory Study on Spinal Cord Injury, Chronic Inflammation, Immune Modulation, published in Biology (Basel) (2024) — summary generated from the PubMed abstract.
- 2024
Biology (Basel) - Level CProspective StudyPubMed
Delayed onset, immunomodulation, and lifespan improvement of SOD1 G93A mice after intravenous injection of human mesenchymal stem cells derived from adipose tissue.
Prospective Study on Neuroinflammation, Immune Modulation, published in Brain Res Bull (2022) — summary generated from the PubMed abstract.
- 2022
Brain Res Bull - Level DNarrative ReviewPubMed
Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?
Narrative Review on Immune Modulation, published in Cell Death Dis (2022) — summary generated from the PubMed abstract.
- 2022
Cell Death Dis454 citations - Level DAnimal StudyEurope PMC
Immunomodulation of Pluripotent Stem Cell-Derived Mesenchymal Stem Cells in Rotator Cuff Tears Model
Animal Study on Rotator Cuff, Shoulder Pain, Chronic Inflammation, Immune Modulation, published in Biomedicines (2022) — summary generated from the PubMed abstract.
- 2022
Biomedicines2 citations - Level BClinical TrialEurope PMC
Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19
Clinical Trial on Immune Modulation, published in Int J Mol Sci (2022) — summary generated from the PubMed abstract.
- 2022
Int J Mol Sci19 citations - Level BClinical TrialEurope PMC
Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm
Clinical Trial on Cardiovascular Disease, Immune Modulation, published in Stem Cells (2021) — summary generated from the PubMed abstract.
- 2021
Stem Cells41 citations - Level DNarrative ReviewEurope PMC
The Latest Developments in Immunomodulation of Mesenchymal Stem Cells in the Treatment of Intrauterine Adhesions, Both Allogeneic and Autologous
Narrative Review on Immune Modulation, published in Front Immunol (2021) — summary generated from the PubMed abstract.
- 2021
Front Immunol30 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease
Narrative Review on Cardiovascular Disease, Immune Modulation, published in Front Cell Dev Biol (2021) — summary generated from the PubMed abstract.
- 2021
Front Cell Dev Biol24 citations - Level DNarrative ReviewPubMed
DNA methylation and demethylation link the properties of mesenchymal stem cells: Regeneration and immunomodulation.
Narrative Review on Immune Modulation, published in World J Stem Cells (2020) — summary generated from the PubMed abstract.
- 2020
World J Stem Cells - Level BClinical TrialEurope PMC
Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics
Clinical Trial on Immune Modulation, published in Life Sci (2020) — summary generated from the PubMed abstract.
- 2020
Life Sci26 citations - Level DLaboratory StudyPubMed
A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
Laboratory Study on Chronic Wound, Chronic Inflammation, Immune Modulation, published in J Immunol Methods (2020) — summary generated from the PubMed abstract.
- 2020
J Immunol Methods - Level BClinical TrialEurope PMC
Roles of Mesenchymal Stem Cells in Tissue Regeneration and Immunomodulation
Clinical Trial on Immune Modulation, published in Biomol Ther (Seoul) (2019) — summary generated from the PubMed abstract.
- 2019
Biomol Ther (Seoul)112 citations - Level DNarrative ReviewPubMed
Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System.
Narrative Review on Immune Modulation, Autoimmune Research, published in Stem Cells Int (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cells Int - Level DAnimal StudyEurope PMC
Impact of bone marrow mesenchymal stem cell immunomodulation on the osteogenic effects of laponite
Animal Study on Immune Modulation, published in Stem Cell Res Ther (2018) — summary generated from the PubMed abstract.
- 2018
Stem Cell Res Ther44 citations - Level DAnimal StudyPubMed
The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
Animal Study on Immune Modulation, published in Transplantation (2017) — summary generated from the PubMed abstract.
- 2017
Transplantation - Level DLaboratory StudyPubMed
Molecular Mechanisms of Immunomodulation Properties of Mesenchymal Stromal Cells: A New Insight into the Role of ICAM-1.
Laboratory Study on Chronic Inflammation, Immune Modulation, published in Stem Cells Int (2017) — summary generated from the PubMed abstract.
- 2017
Stem Cells Int
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406